In addition, TOMM20 downregulation using CRISPR‐Cas9 reduced all known BCL2 apoptosis inhibitory proteins in chondrosarcoma (CH2879) and fibrosarcoma (MCA205). This evidence concerns the gene BCL2 and fibrosarcoma.